Log in

Well differentiated carcinoma with a poor prognosis: a retrospective analysis of papillary gastric adenocarcinoma

  • Original Article
  • Published:
Surgery Today Aims and scope Submit manuscript

Abstract

Purpose

To explore the clinicopathological features and prognosis of papillary gastric adenocarcinoma (PGC).

Methods

The subjects of this retrospective analysis were 1525 patients with gastric cancer in a single center in China.

Results

The patients with PGC were generally of advanced age and the tumor was located in the upper 1/3 of the stomach. PGC was well or moderately differentiated, with serosal infiltration, early lymph node metastasis, TNM stages I/II, liver metastasis, and a short postoperative overall survival time. Patients with the secondary pathological type of papillary adenocarcinoma presented with clinicopathological similarities to those with primary PGC. PGC was a risk factor for poor survival in both univariate and multivariate analyses.

Conclusion

Papillary gastric adenocarcinoma (PGC) showed different clinicopathological characteristics and prognosis to other types of gastric cancer (GC), even if it was not the primary pathological type. The higher the proportion of papillary adenocarcinoma in gastric cancer samples, the shorter the postoperative survival time of patients. PGC needs further multicenter studies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Canada)

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Yasuda K, Adachi Y, Shiraishi N, Maeo S, Kitano S. Papillary adenocarcinoma of the stomach. Gastric Cancer. 2000;3(1):33–8.

    Article  Google Scholar 

  2. Hu B, El Hajj N, Sittler S, Lammert N, Barnes R, Meloni-Ehrig A. Gastric cancer: classification, histology and application of molecular pathology. J Gastrointest Oncol. 2012;3(3):251–61.

    PubMed  PubMed Central  Google Scholar 

  3. Sitarz R, Skierucha M, Mielko J, Offerhaus GJA, Maciejewski R, Polkowski WP. Gastric cancer: epidemiology, prevention, classification, and treatment. Cancer Manag Res. 2018;10:239–48.

    Article  CAS  Google Scholar 

  4. Zhang W, Cui C, Wang J. Gastric cancer in young patients-an analysis of 142 cases. Chin J Med Guide. 2015;4:325–7.

    Google Scholar 

  5. Leung WK, Wu M-S, Kakugawa Y, Kim JJ, Yeoh K-G, Goh KL, et al. Screening for gastric cancer in Asia: current evidence and practice. Lancet Oncol. 2008;9(3):279–87.

    Article  Google Scholar 

  6. Yu Y, Zhu Z. The interpretation of WHO classification of tumors of the digestive system (2010 edition) (in Chinese). J Surg Concepts Pract. 2011;5:508–12.

    Google Scholar 

  7. Bosman FT, Carneiro F, Hruban RH, Theise ND. WHO classification of tumours of the digestive system. WHO classification of tumors of the digestive system. 2010.

  8. Association JGC. Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer. Kanagawa: Association JGC; 2011.

    Google Scholar 

  9. Uesugi N, Sugai T, Sugimoto R, Eizuka M, Fujita Y, Sato A, et al. Clinicopathological and molecular stability and methylation analyses of gastric papillary adenocarcinoma. Pathology. 2017;49(6):596–603.

    Article  CAS  Google Scholar 

  10. Uefuji K, Ichikura T, Tamakuma S. Clinical and prognostic characteristics of papillary clear carcinoma of stomach. Surg Today. 1996;26(3):158–63.

    Article  CAS  Google Scholar 

  11. Eom DW, Kang GH, Han SH, Cheon GJ, Han KH, Oh HS, et al. Gastric micropapillary carcinoma. Am J Surg Pathol. 2011;35(1):84–91.

    Article  Google Scholar 

  12. Min BH, Byeon SJ, Lee JH, Kim KM, An JY, Choi MG, et al. Lymphovascular invasion and lymph node metastasis rates in papillary adenocarcinoma of the stomach: implications for endoscopic resection. Gastric Cancer. 2018;21(4):680–8.

    Article  Google Scholar 

  13. Maehara Y. Pertinent risk factors and gastric carcinoma with synchronous peritoneal dissemination or liver metastasis. Surgery. 1991;5(110):820–3.

    Google Scholar 

  14. Kaibara N, Kimura O, Nishidoi H, Makino M, Kawasumi H, Koga S. High incidence of liver metastasis in gastric cancer with medullary growth pattern. J Surg Oncol. 1985;28(3):195–8.

    Article  CAS  Google Scholar 

  15. Ye X. Correlation analysis on gastric cancer pathological ty** and prognosis. Int Med Health Guidance News. 2012;18(20):3009–11.

    Google Scholar 

  16. Lee HJ, Kim GH, Park DY, Kim YK, Jeon HK, Lee BE, et al. Endoscopic submucosal dissection for papillary adenocarcinoma of the stomach: is it really safe? Gastric Cancer. 2017;20(6):978–86.

    Article  Google Scholar 

  17. Sekiguchi M, Kushima R, Oda I, Suzuki H, Taniguchi H, Sekine S, et al. Clinical significance of a papillary adenocarcinoma component in early gastric cancer: a single-center retrospective analysis of 628 surgically resected early gastric cancers. J Gastroenterol. 2015;50(4):424–34.

    Article  Google Scholar 

  18. Yu Y. Evaluation of traditional pathological classification at molecular classification era for gastric cancer. Chin J Gastrointes Surg. 2014;17(1):18–20.

    Google Scholar 

  19. Cui J, Liang H, Deng J, Ding X, Pan Y, Zhang L, et al. Clinical significance of Lauren ty** in the prognosis evaluation of gastric cancer. Chin J Dig. 2014;34(7):449–52.

    Google Scholar 

  20. Yu H, Fang C, Chen L, Shi J, Fan X, Zou X, et al. Worse prognosis in papillary, compared to tubular, early gastric carcinoma. J Cancer. 2017;8(1):117–23.

    Article  Google Scholar 

  21. Nakashima Y, Yao T, Hirahashi M, Aishima S, Kakeji Y, Maehara Y, et al. Nuclear atypia grading score is a useful prognostic factor in papillary gastric adenocarcinoma. Histopathology. 2011;59(5):841–9.

    Article  Google Scholar 

  22. Zhang Q, Ming J, Zhang S, Li B, Yin L, Qiu X. Micropapillary component in gastric adenocarcinoma: an aggressive variant associated with poor prognosis. Gastric Cancer. 2015;18(1):93–9.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This study was supported in part by grants from the Programs of National Natural Science Foundation of China (No. 81572372), National Key Research and Development Program of China (2016YFC1303202), and National Precision Medicine Research Program (2017YFC0908300).

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to **gyu Deng or Han Liang.

Ethics declarations

Conflict of interest

We have no conflicts of interest to declare.

Ethical standards

All authors are accountable for all aspects of the work. Informed consent for inclusion in the study was obtained from all patients. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, X., Deng, J. & Liang, H. Well differentiated carcinoma with a poor prognosis: a retrospective analysis of papillary gastric adenocarcinoma. Surg Today 51, 1387–1396 (2021). https://doi.org/10.1007/s00595-021-02289-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00595-021-02289-3

Keywords

Navigation